Abstract
Understanding of the pharmacology of thrombolytics, anticoagulants, and antiplatelets is critical to performing safe and effective endovascular therapy for acute ischemic therapy. This is a basic review of the clinical pharmacologic data on the anticoagulants, antiplatelets, and fibrinolytic agents most commonly used in the treatment of stroke and in the neurointerventional suite.
MeSH terms
-
Animals
-
Anticoagulants / pharmacology*
-
Anticoagulants / therapeutic use
-
Blood Platelets / drug effects
-
Blood Platelets / metabolism
-
Fibrinolytic Agents / pharmacology*
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Platelet Aggregation Inhibitors / pharmacology*
-
Platelet Aggregation Inhibitors / therapeutic use
-
Stroke / drug therapy*
-
Stroke / metabolism
-
Stroke / pathology
-
Thrombolytic Therapy / methods
-
Thrombolytic Therapy / trends
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors